These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37541149)

  • 1. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation: Insights from the OCEAN-TAVI Registry.
    Koga M; Izumo M; Yoneyama K; Akashi YJ; Yashima F; Tada N; Yamawaki M; Shirai S; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
    Am J Cardiol; 2023 Oct; 204():130-139. PubMed ID: 37541149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation for Aortic Stenosis.
    Tobe A; Tanaka A; Tokuda Y; Akita S; Fujii T; Miki Y; Furusawa K; Ishii H; Usui A; Murohara T
    Circ J; 2021 Jun; 85(7):1093-1098. PubMed ID: 34039838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of Different ECG Left Ventricular Hypertrophy in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Yang Y; Ahn JM; Kang DY; Ko E; Kim S; Kim TO; Kim JH; Lee J; Lee SA; Kim DH; Kim HJ; Kim JB; Choo SJ; Park SJ; Park DW
    J Am Heart Assoc; 2022 Feb; 11(4):e023647. PubMed ID: 35112886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of electrocardiographic left ventricular hypertrophy is associated with increased mortality after transcatheter aortic valve replacement.
    Kampaktsis PN; Ullal AV; Swaminathan RV; Minutello RM; Kim L; Bergman GS; Feldman DN; Singh H; Wong SC; Okin PM
    Clin Cardiol; 2018 Sep; 41(9):1246-1251. PubMed ID: 30062778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
    Yamabe S; Dohi Y; Higashi A; Kinoshita H; Sada Y; Hidaka T; Kurisu S; Shiode N; Kihara Y;
    Heart Vessels; 2016 Sep; 31(9):1497-503. PubMed ID: 26531830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
    Yoshijima N; Yanagisawa R; Hase H; Tanaka M; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Araki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Higashimori A; Watanabe Y; Yamamoto M; Hayashida K;
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):35-44. PubMed ID: 30977256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of electrocardiographic left ventricular hypertrophy following transcatheter aortic valve replacement.
    Tanaka T; Yahagi K; Asami M; Ninomiya K; Kikushima H; Okuno T; Horiuchi Y; Yuzawa H; Komiyama K; Tanaka J; Yokozuka M; Miura S; Aoki J; Tanabe K
    J Cardiol; 2021 Apr; 77(4):346-352. PubMed ID: 33455846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in patients undergoing transcatheter aortic valve replacement.
    Sjöberg S; Sundh F; Schlegel T; Maynard C; Rück A; Wagner G; Ugander M
    J Electrocardiol; 2015; 48(4):630-6. PubMed ID: 25865909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.
    Gonzales H; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
    JACC Cardiovasc Interv; 2020 Jun; 13(11):1329-1339. PubMed ID: 32499024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
    JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between valvuloarterial impedance after transcatheter aortic valve implantation and 2-year mortality in elderly patients with severe symptomatic aortic stenosis: the OCEAN-TAVI registry.
    Nagura F; Kataoka A; Hara M; Kozuma K; Watanabe Y; Nakashima M; Hioki H; Kawashima H; Nara Y; Shirai S; Tada N; Araki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Higashimori A; Takagi K; Yamamoto M; Hayashida K;
    Heart Vessels; 2019 Jun; 34(6):1031-1039. PubMed ID: 30599060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
    Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Sex on Mortality and Left Ventricular Remodeling After Transcatheter Aortic Valve Implantation.
    Shishido K; Yamanaka F; Ochiai T; Moriyama N; Yokoyama H; Yokota S; Noguchi K; Yashima F; Tada N; Naganuma T; Araki M; Shirai S; Ueno H; Mizutani K; Tabata M; Takagi K; Watanabe Y; Yamamoto M; Saito S; Hayashida K
    Circ J; 2021 Jun; 85(7):979-988. PubMed ID: 33907051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement.
    Ito N; Zen K; Takahara M; Tani R; Nakamura S; Fujimoto T; Takamatsu K; Yashige M; Kadoya Y; Yamano M; Yamano T; Nakamura T; Yaku H; Matoba S
    ESC Heart Fail; 2023 Apr; 10(2):1336-1346. PubMed ID: 36725669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of electrocardiographic left ventricular hypertrophy and poor outcome in patients undergoing transcatheter aortic valve replacement-A systematic review and meta-analysis.
    Martha JW; Pranata R; Yonas E; Wibowo A; Akbar MR
    J Card Surg; 2021 Jul; 36(7):2233-2239. PubMed ID: 33768590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of electrocardiographic left ventricular hypertrophy in patients undergoing Transcatheter aortic valve replacement is associated with increased mortality.
    Zhang R; Jou S; Cao Y; Keller K; Xiao E; de La Rosa A; DeLago A; El-Hajjar M; Torosoff M
    J Electrocardiol; 2020; 63():12-16. PubMed ID: 33017756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Serum C-Reactive Protein Level on Admission to Predict Mortality After Transcatheter Aortic Valve Implantation.
    Hioki H; Watanabe Y; Kozuma K; Yamamoto M; Naganuma T; Araki M; Tada N; Shirai S; Yamanaka F; Higashimori A; Mizutani K; Tabata M; Takagi K; Ueno H; Hayashida K;
    Am J Cardiol; 2018 Jul; 122(2):294-301. PubMed ID: 29735216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of residual left ventricular hypertrophy and systolic dysfunction in aortic stenosis following transcatheter aortic valve replacement.
    Pedersen ALD; Povlsen JA; Rasmussen VG; Frederiksen CA; Christiansen EH; Terkelsen CJ; Vase H; Poulsen SH
    Int J Cardiovasc Imaging; 2023 Jan; 39(1):13-22. PubMed ID: 36598683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: A sub-analysis of the WIN-TAVI registry.
    Spaziano M; Chieffo A; Watanabe Y; Chandrasekhar J; Sartori S; Lefèvre T; Petronio AS; Presbitero P; Tchetche D; Iadanza A; Van Mieghem NM; Mehilli J; Mehran R; Morice MC;
    J Cardiovasc Comput Tomogr; 2018; 12(4):338-343. PubMed ID: 29735255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.